Penumbra

Penumbra, founded in 2004, is a global leader in the medical devices and equipment industry. The company specializes in the design, development, and manufacturing of innovative neurovascular access systems and aspiration-based thrombectomy technologies. With a robust portfolio including brands like Neuron, Indigo, and the Penumbra System, the firm addresses critical patient needs in neurovascular and peripheral vascular therapies. Meet Penumbra's team to understand the leadership driving these clinical advancements.

Operating with 1,000-5,000 employees, Penumbra maintains a significant international footprint across North America, Europe, and Asia. The company leverages its expertise to provide advanced medical solutions to healthcare providers globally. Learn about Penumbra's global headquarters for detailed information regarding their operational base in Alameda, California, and their extensive network of eight global locations. Their commitment to R&D ensures they remain at the forefront of medical technology.

As a publicly traded entity on the NYSE under the ticker PEN, the company demonstrates strong market performance. With annual revenue reaching $1.5B, Penumbra continues to compete effectively against major industry players like Edwards Lifesciences and Teleflex. The company’s strategic focus on mechanical thrombectomy and revascularization devices supports its growth trajectory in the competitive medical device sector. Explore financial highlights to review detailed fiscal metrics and funding history, including their 2015 stock offering.